The pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a serious global health threat. Since no specific therapeutics are available, researchers around the world screened compounds to inhibit various molecular targets of SARS-CoV-2 including its main protease (M pro ) essential for viral replication. Due to the high urgency of these discovery efforts, off-target binding, which is one of the major reasons for drug-induced toxicity and safety-related drug attrition, was neglected. Here, we used molecular docking, toxicity profiling, and multiple molecular dynamics (MD) protocols to assess the selectivity of 33 reported non-covalent inhibitors of SARS-CoV-2 M pro against eight proteases and 16 anti-targets. The panel of proteases included SARS-CoV M pro , cathepsin G, caspase-3, ubiquitin carboxy-terminal hydrolase L1 (UCHL1), thrombin, factor Xa, chymase, and prostasin. Several of the assessed compounds presented considerable off-target binding towards the panel of proteases, as well as the selected anti-targets. Our results further suggest a high risk of off-target binding to chymase and cathepsin G. Thus, in future discovery projects, experimental selectivity assessment should be directed toward these proteases. A systematic selectivity assessment of SARS-CoV-2 M pro inhibitors, as we report it, was not previously conducted.
【저자키워드】 coronavirus, SARS, protease, selectivity, structure-based design, 【초록키워드】 SARS-CoV-2, coronavirus, pandemic, protocol, molecular docking, Toxicity, molecular dynamics, protease, severe acute respiratory syndrome Coronavirus, inhibitors, Health, Viral, viral replication, target, targets, Proteases, selectivity, molecular, respiratory, caspase, attrition, binding, cathepsin, high risk, caspase-3, thrombin, factor Xa, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, inhibitors of SARS-CoV-2, Compound, M pro, urgency, molecular target, researcher, chymase, UCHL1, selected, reported, inhibit, conducted, eight, screened, SARS-CoV M, 【제목키워드】 SARS-CoV-2, assessment,